| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/12/2009 | US20090041659 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse |
| 02/12/2009 | DE102007036128A1 Antibiotische Peptide Antimicrobial peptides |
| 02/12/2009 | CA2695897A1 Method of identifying individuals at risk of thiopurine drug resistance and intolerance |
| 02/12/2009 | CA2695894A1 Baculoviral vectors with a dual vertebrate and baculovirus promoter controlling an immunogenic fusion gene |
| 02/12/2009 | CA2695849A1 Method of producing heterogeneous proteins |
| 02/12/2009 | CA2695811A1 A plant regulatory region that directs transgene expression in the maternal and supporting tissue of maize ovules and pollinated kernels |
| 02/12/2009 | CA2695809A1 Plant bioreactor for the production of interleukin-24 cytokine |
| 02/12/2009 | CA2695530A1 Msca1 nucleotide sequences impacting plant male fertility and method of using same |
| 02/12/2009 | CA2695510A1 Translation initiation region sequences for the optimal expression of heterologous proteins |
| 02/12/2009 | CA2695505A1 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency |
| 02/12/2009 | CA2695495A1 Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof |
| 02/12/2009 | CA2695491A1 [nife]-hydrogenases having an improved resistance to dioxygen, process for obtaining them and their applications |
| 02/12/2009 | CA2695487A1 Genes and proteins for the biosynthesis of the lantibiotic 107891 |
| 02/12/2009 | CA2695433A1 Lentiviral gene transfer vectors and their medicinal applications |
| 02/12/2009 | CA2695061A1 Sdf-1 binding nucleic acids and the use thereof |
| 02/12/2009 | CA2693237A1 Composition and method for treatment of reperfusion injury and tissue damage |
| 02/12/2009 | CA2663580A1 Bioactive peptides and method of using same |
| 02/11/2009 | EP2022861A1 Method for detecting disease-related marker using gastric mucosal lavage fluid |
| 02/11/2009 | EP2022856A2 Improvements in or relating to binding proteins for recognition of DNA |
| 02/11/2009 | EP2022855A1 High secretion production method of protein |
| 02/11/2009 | EP2022854A1 Phage-displaying single-chain antibody capable of recognizing non-reduced mannose residue |
| 02/11/2009 | EP2022853A1 Freeze-dried product for transferring nucleic acid, oligonucleic acid or derivative thereof |
| 02/11/2009 | EP2022852A1 Method for production of optically active amine compound, recombinant vector, and transformant carrying the vector |
| 02/11/2009 | EP2022851A1 Method of transferring substance into cell |
| 02/11/2009 | EP2022800A2 Compositions for the therapy and diagnosis of ovarian cancer |
| 02/11/2009 | EP2022799A2 Polycistronic expression of antibodies |
| 02/11/2009 | EP2022797A2 Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer |
| 02/11/2009 | EP2022339A1 Artificial diet for lepidopteran and method for producing the same, lepidopteran and method for producing the same, and biomaterial |
| 02/11/2009 | EP2021505A2 Men1 is a marker and therapeutic target for breast and prostate cancer |
| 02/11/2009 | EP2021498A1 Identification of tumor suppressor genes in an acute myeloid leukaemia model |
| 02/11/2009 | EP2021490A2 Rpa optimization |
| 02/11/2009 | EP2021489A2 Codon optimization method |
| 02/11/2009 | EP2021485A2 System for transposing hyperactive recombinant derivatives of mos-1 transposon |
| 02/11/2009 | EP2021484A1 Expression vectors comprising the hs1 promoter of the vav1 oncogene and use thereof for the preparation of pharmaceutical compositions intended for somatic gene therapy |
| 02/11/2009 | EP2021483A1 Biomolecule surface display and uses thereof |
| 02/11/2009 | EP2021482A1 Treatment of an infection by an rna virus due to an rna dependent rna polymerase |
| 02/11/2009 | EP2021481A2 Improvements in or relating to starch storage in plants |
| 02/11/2009 | EP2021479A2 Modified molecule |
| 02/11/2009 | EP2021478A2 Delta5 desaturase and its use in making polyunsaturated fatty acids |
| 02/11/2009 | EP2021477A2 Genetic markers for high oleic acid content in plants |
| 02/11/2009 | EP2021476A1 Corn plant and seed corresponding to transgenic event mon89034 and methods for detection and use thereof |
| 02/11/2009 | EP2021475A1 High-affinity antagonists of elr-cxc chemokines |
| 02/11/2009 | EP2021474A2 Rage fusion proteins, formulations, and methods of use thereof |
| 02/11/2009 | EP2021473A1 A method for stimulating angiogenesis using dkk2 and composition comprising the same |
| 02/11/2009 | EP2021472A2 Compounds and methods for modulating gene expression |
| 02/11/2009 | EP2021471A1 Screening method |
| 02/11/2009 | EP2021470A1 A method for preparing compounds by nucleic acid directed synthesis |
| 02/11/2009 | EP2021469A2 Peptide library |
| 02/11/2009 | EP2021468A2 Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2 |
| 02/11/2009 | EP2021466A1 Cloning and expression of a novel phytase |
| 02/11/2009 | EP2021371A2 Monoclonal antibodies specific for pancreatic endocrine, exocrine or ductal cells |
| 02/11/2009 | EP2021366A2 Production of proteins carrying oligomannose or human-like glycans in yeast and methods use thereof |
| 02/11/2009 | EP2021364A1 Improved antimicrobial peptides |
| 02/11/2009 | EP2021359A1 Enzymes for degrading herbicides |
| 02/11/2009 | EP2021352A2 Treatment of protein misfolding |
| 02/11/2009 | EP2021098A2 Device and method for the reduction of emissions |
| 02/11/2009 | EP2021009A2 Methods to improve creatine kinase metabolism and contractile function in cardiac muscle for the treatment of heart failure |
| 02/11/2009 | EP2020846A2 Compositions for silencing the expression of gibberellin 2-oxidase and uses thereof |
| 02/11/2009 | EP1910414A4 Polynucleotides and polypeptides of the il-12 family of cytokines |
| 02/11/2009 | EP1846560A4 Novel omega-3 fatty acid desaturase family members and uses thereof |
| 02/11/2009 | EP1841870A4 Nitrogen-regulated sugar sensing gene and protein and modulation thereof |
| 02/11/2009 | EP1809749B1 Methods for heterologous expression of secondary metabolites |
| 02/11/2009 | EP1648929B1 Active subfragments of human histidine rich glycoprotein |
| 02/11/2009 | EP1636340A4 Unnatural reactive amino acid genetic code additions |
| 02/11/2009 | EP1594968B1 Fireproof roller shutters and method for producing a fireproof roller shutter |
| 02/11/2009 | EP1572679B1 Crfr1 selective ligands |
| 02/11/2009 | EP1478236B1 Targeted retrograde gene delivery to motor neurons |
| 02/11/2009 | EP1463808B1 High fidelity dna polymerase compositions and uses therefor |
| 02/11/2009 | EP1444367B1 Reca-negative and rhab-negative microorganism |
| 02/11/2009 | EP1409012B1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 02/11/2009 | EP1368629B1 Magnetic isolation and purification of nucleic acids |
| 02/11/2009 | EP1358352B1 Solid support assay systems and methods utilizing non-standard bases |
| 02/11/2009 | EP1259258B1 Gm-negative ehv-mutants |
| 02/11/2009 | EP1210453B1 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 02/11/2009 | EP1169434B1 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| 02/11/2009 | EP1109577B1 Multicomponent vaccines against Staphylococcus aureus |
| 02/11/2009 | EP1042466B1 Polypeptides, polynucleotides and uses thereof |
| 02/11/2009 | EP0946731B1 Non-m non-o hiv strains, fragments and applications |
| 02/11/2009 | EP0879244B1 Mycoplasma recombinant polypeptide and vaccines |
| 02/11/2009 | EP0784059B1 Polynucleotides encoding an antigenic polypeptide of chlamydia pneumoniae |
| 02/11/2009 | CN101365944A Methods for gene mapping and haplotyping |
| 02/11/2009 | CN101365799A Method for preparing antibodies selective for activating Fc receptors |
| 02/11/2009 | CN101365796A Methods for controlling pests using rnai |
| 02/11/2009 | CN101365795A Dsrna used as pest control agent |
| 02/11/2009 | CN101365794A Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 02/11/2009 | CN101365793A Polypeptide extracted from plants of the genus lupinus or produced in recombinant form, nucleotide sequence encoding it and its use in animal nutrition, as a plant growth promoter and in the fight aga |
| 02/11/2009 | CN101365792A Anti-hepatitis b virus ribozymal nucleic acid |
| 02/11/2009 | CN101365791A Method for replication of nucleic acid and novel artificial base pair |
| 02/11/2009 | CN101365788A Delta-9 elongases and their use in making polyunsaturated fatty acids |
| 02/11/2009 | CN101365786A Plants having improved growth characteristics and methods for making the same |
| 02/11/2009 | CN101365785A Process and materials for production of glucosamine and n-acetylglucosamine |
| 02/11/2009 | CN101365720A Fully human hybridoma fusion partner cell lines |
| 02/11/2009 | CN101365494A Compositions and methods for treatment of autoimmune disease |
| 02/11/2009 | CN101365472A LOPAP-based pharmaceutical compositions and uses thereof |
| 02/11/2009 | CN101365416A Chimeric keratin-binding effector proteins |
| 02/11/2009 | CN101363064A Standard substance for detecting influenza a virus load and detection method thereof |
| 02/11/2009 | CN101363063A Primer, probe, kit and method for detecting A, B and H5 subtype influenza virus by triple fluorescent quantitative RT-PCR |
| 02/11/2009 | CN101363060A Two gene makers for identifying rice and fragrant rice gene fgr |
| 02/11/2009 | CN101363055A Molecule specificity making primer of mushroom Cr02 bacterial and detection method |
| 02/11/2009 | CN101363045A Method for separating and purifying biological target material using ultrafine magnet particle |